SleepFix for Youth: Digital Behavioural Therapy for Insomnia With E-Psychologist Support

ConditionInsomnia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-24
SponsorWoolcock Institute of Medical Research

About this trial

This pilot randomised, open-label, parallel-group controlled trial will evaluate the feasibility, acceptability and effects of a psychologist-supported digital behavioural therapy for insomnia (dBTi) compared to a wait-listed active control (digital sleep health education) in young people aged 16-24 years with insomnia symptoms.

The primary objectives are to evaluate the feasibility of conducting a full-scale trial by assessing recruitment, consent and randomisation rates, intervention uptake, and data completeness. Secondary objectives include exploring treatment effects on insomnia severity (Insomnia Severity Index), sleep diary metrics, sleep quality, fatigue, and mood (depression and anxiety symptoms). Post-intervention interviews will assess participant experience and acceptability.

Results will inform the design of a larger randomised controlled trial.

Eligibility criteria

Qualifiers

16 -24 years old

Able to give informed online consent and if younger <18years old guardian/parental consent

Insomnia Severity Index ≥ 10

English fluency

Disqualifiers

Shift-workers with regular shifts between the hours of 8pm and 8am.

Recent travel to a destination with >2 hours time difference (within last 7-days and with subjective reports that they are not experiencing jet lag).

Serious medical and/or psychiatric illnesses/disorders (e.g., Epilepsy or other seizure disorders, heart failure, bipolar disorder, schizophrenia, Major Depressive disorder)

Self-reported/diagnosed sleep disorders other than insomnia (e.g. - Obstructive Sleep Apnoea, REM/NREM sleep disorders, Restless Leg Syndrome, Narcolepsy, free running cycle & Circadian rhythm disorder)

Trial design

Treatments tested in this trial

  • SleepFix + e-psychologist support calls
  • Sleep Health Education (Active control)

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Woolcock Institute of Medical Research

Lead sponsor

Macquarie University, Australia

Collaborator